AliveX
Alive X Biotech leverages artificial intelligence and multi-omics data to enhance drug development for immune-mediated diseases. Their platform integrates computational biology with knowledge-empowered Model-Informed Drug Development (MIDD), aiming to improve the success rate of drug development while reducing costs and time. The company focuses on interdisciplinary collaboration among immunologists, molecular biologists, and data scientists to tackle complex challenges in life sciences, ultimately transforming research and developing personalized clinical solutions.
AliveX
Alive X Biotech leverages artificial intelligence and multi-omics data to enhance drug development for immune-mediated diseases. Their platform integrates computational biology with knowledge-empowered Model-Informed Drug Development (MIDD), aiming to improve the success rate of drug development while reducing costs and time. The company focuses on interdisciplinary collaboration among immunologists, molecular biologists, and data scientists to tackle complex challenges in life sciences, ultimately transforming research and developing personalized clinical solutions.